Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €4.91 EUR
Change Today -0.095 / -1.90%
Volume 265.9K
As of 11:35 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gert-Jan Renardel de Lavalette

Former Chief Operating Officer, MDxHealth SA
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

53--

Background*

Mr. Gert-Jan Renardel de Lavalette served as the Chief Operating Officer of MDxHealth SA (formerly OncoMethylome Sciences) since February 2, 2009. Mr. de Lavalette focused on the development and commercialization of the numerous products of MDxHealth SA. He has over 20 years of experience in the diagnostics and pharmaceutical industry from his previous management positions at Schering-Plough and Akzo Nobel.

Corporate Headquarters*

CAP Business Center
Herstal, Liège 4040

Belgium

Phone: 32 4 364 20 70
Fax: 32 4 364 20 71

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDXH:BB €4.91 EUR -0.095

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Valerie Barber Palmieri Chief Executive Officer and President
Vermillion, Inc.
--
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Russell Cummings Chief Executive Officer, Executive Director and Member of Investment Committee
Imperial Innovations Group plc
403.0K GBP
Kevin B. Kowbel Chairman and Interim Chief Executive Officer
Health Discovery Corporation
--
Christopher J. Moreau Chief Executive Officer, President and Non Independent Director
Miraculins Inc.
C$247.9K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MDXHEALTH, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.